We are live on
!
Find out more
Parallel Advisors Portfolio holdings
AUM
$6.56B
Turnover
11.49%
1-Year Est. Return
32.24%
This Fund
S&P 500
This Quarter
Est. Return
+8.88%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.41%
10 Year Est. Return
–
AUM
$5B
AUM Growth
+$569M
(+13%)
Cap. Flow
+$104M
Cap. Flow
% of AUM
2.08%
Top 10 Holdings %
Top 10 Hldgs %
38.84%
Holding
3,762
New
251
Increased
1,450
Reduced
1,277
Closed
224
Avg Time Held Equity + Options
4.7
years
Top 10 Avg Time Held Equity + Options
2.9
years
Top 20 Avg Time Held Equity + Options
3.8
years
Avg Time Held Equity only
4.7
years
Top 10 Avg Time Held Equity only
2.9
years
Top 20 Avg Time Held Equity only
3.8
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$18.4M |
| 2 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$9.77M |
| 3 |
BlackRock US Equity Factor Rotation ETF
DYNF
|
+$5.48M |
| 4 |
Microsoft
MSFT
|
+$4.93M |
| 5 |
Vanguard S&P 500 ETF
VOO
|
+$4.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Corcept Therapeutics
CORT
|
+$7.34M |
| 2 |
Starbucks
SBUX
|
+$4.7M |
| 3 |
iShares California Muni Bond ETF
CMF
|
+$3.3M |
| 4 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$2.63M |
| 5 |
Vanguard Morningstar Small-Cap ETF
VB
|
+$1.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 46.71% |
| 2 | Technology | 17.21% |
| 3 | Healthcare | 9.68% |
| 4 | Financials | 7.2% |
| 5 | Communication Services | 5.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2801
Net Lease Office Properties
NLOP
$144M
| $3.78K | ﹤0.01% |
116
-75
| -39% | -$2.29K |
2023 Q4
6 quarters
|
|
2802
Cognyte Software
CGNT
$636M
| $3.77K | ﹤0.01% |
408
| – | – |
2023 Q3
7 quarters
|
|
2803
Independent Bank Corp
IBCP
$790M
| $3.76K | ﹤0.01% |
116
| – | – |
2024 Q1
5 quarters
|
|
2804
Pacer Global Cash Cows Dividend ETF
GCOW
$3.59B
| $3.76K | ﹤0.01% |
+99
| New | +$3.65K |
2025 Q2
0 quarters
|
|
2805
Scholar Rock
SRRK
$4.86B
| $3.75K | ﹤0.01% |
106
+10
| +10% | +$314 |
2023 Q3
7 quarters
|
|
2806
Invesco S&P 500 Revenue ETF
RWL
$10.1B
| $3.75K | ﹤0.01% |
+36
| New | +$3.56K |
2025 Q2
0 quarters
|
|
2807
Gladstone Investment Corp
GAIN
$599M
| $3.75K | ﹤0.01% |
263
-102
| -28% | -$1.42K |
2022 Q4
10 quarters
|
|
2808
iShares High Yield Systematic Bond ETF
HYDB
$1.54B
| $3.75K | ﹤0.01% |
79
| – | – |
2024 Q4
2 quarters
|
|
2809
New Fortress Energy
NFE
$23.7M
| $3.75K | ﹤0.01% |
23
-40
| -63% | -$8.69K |
2021 Q4
14 quarters
|
|
2810
Newmark Group
NMRK
$2.15B
| $3.74K | ﹤0.01% |
308
-14
| -4% | -$157 |
2019 Q4
22 quarters
|
|
2811
Cohen & Steers Quality Income Realty Fund
RQI
$1.51B
| $3.73K | ﹤0.01% |
300
-100
| -25% | -$1.22K |
2016 Q4
34 quarters
|
|
2812
CVR Energy
CVI
$6.17B
| $3.73K | ﹤0.01% |
+139
| New | +$3.06K |
2025 Q2
0 quarters
|
|
2813
PubMatic
PUBM
$758M
| $3.73K | ﹤0.01% |
300
| – | – |
2021 Q4
14 quarters
|
|
2814
Stratasys
SSYS
$608M
| $3.73K | ﹤0.01% |
325
-100
| -24% | -$1.01K |
2023 Q1
9 quarters
|
|
2815
LXP Industrial Trust
LXP
$3.6B
| $3.72K | ﹤0.01% |
90
-69
| -43% | -$2.84K |
2024 Q3
3 quarters
|
|
2816
Pacific Biosciences
PACB
$538M
| $3.72K | ﹤0.01% |
3,000
-730
| -20% | -$843 |
2024 Q1
5 quarters
|
|
2817
Alphatec Holdings
ATEC
$1.62B
| $3.72K | ﹤0.01% |
335
-94
| -22% | -$1.08K |
2024 Q4
2 quarters
|
|
2818
abrdn Physical Silver Shares ETF
SIVR
$3.85B
| $3.72K | ﹤0.01% |
108
| – | – |
2024 Q3
3 quarters
|
|
2819
Tenable Holdings
TENB
$4.1B
| $3.72K | ﹤0.01% |
110
-10
| -8% | -$325 |
2020 Q2
20 quarters
|
|
2820
DELISTED
Heidrick & Struggles
HSII
| $3.71K | ﹤0.01% |
81
+40
| +98% | +$1.68K |
2024 Q2
4 quarters
|
|
2821
Kura Oncology
KURA
$808M
| $3.7K | ﹤0.01% |
+641
| New | +$3.93K |
2025 Q2
0 quarters
|
|
2822
QCR Holdings
QCRH
$1.62B
| $3.7K | ﹤0.01% |
54
+25
| +86% | +$1.67K |
2020 Q2
20 quarters
|
|
2823
Xtrackers MSCI Europe Hedged Equity ETF
DBEU
$780M
| $3.66K | ﹤0.01% |
83
| – | – |
2022 Q4
10 quarters
|
|
2824
Liberty Energy
LBRT
$2.71B
| $3.63K | ﹤0.01% |
316
+26
| +9% | +$315 |
2020 Q1
21 quarters
|
|
2825
DELISTED
Arcellx
ACLX
| $3.62K | ﹤0.01% |
55
+25
| +83% | +$1.56K |
2024 Q3
3 quarters
|
|
Similar funds
Parallel Advisors's Q2 2025 Portfolio in Review
As of Q2 2025, Parallel Advisors held 3,762 positions worth $5B, up 13% from $4.43B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Parallel Advisors's Q2 2025 filing shows 251 new, 1,450 increased, 1,277 reduced and 224 closed positions. Its largest new stake was Vanguard 0-3 Month Treasury Bill ETF: 32,722 shares worth $2.47M. The largest sale was Corcept Therapeutics, an estimated $7.34M.
By sector, the portfolio is most concentrated in Miscellaneous at 47% of assets, down from 47% a quarter earlier, followed by Technology and Healthcare.
- Parallel Advisors's largest Q2 2025 buy was Vanguard 0-3 Month Treasury Bill ETF: 32,722 shares worth $2.47M.
- Parallel Advisors added most to iShares Core S&P 500 ETF in Q2 2025, an estimated $18.4M increase.
- Parallel Advisors's biggest Q2 2025 reduction was Corcept Therapeutics, cutting an estimated $7.34M.
- Parallel Advisors fully exited Discover Financial Services in Q2 2025, selling an estimated $1.22M.
- Parallel Advisors's ten largest holdings make up 39% of its $5B portfolio in Q2 2025.
- Parallel Advisors opened 251 new positions and closed 224 in Q2 2025.
- Parallel Advisors's portfolio value rose 13% quarter-over-quarter to $5B.
Based on Parallel Advisors's 13F filing for Q2 2025, filed 8 Jul 2025.